During further analysis, patients with PABPC1 showed that high-expression did not have shorter OS and DFS time than those with low-expression at an early stage (I + II) NPC (p = 0.152 and p = 0.241, respectively). The gene discussed is PABPC1; the disease is nasopharyngeal carcinoma.